64984-31-2 Usage
Description
In addition to its transactivational functions, p53 mediates apoptosis by binding with the anti-apoptotic proteins Bcl-xL and Bcl-2 at the mitochondrial surface. Pifithrin-μ (PFT-μ) is an inhibitor of p53-mediated apoptosis, preventing p53 binding to Bcl-xL and Bcl-2 at the mitochondria without affecting p53 transactivational activities In vitro, PFT-μ binds both p53 (Kd = 0.82 mM) and Bcl-xL (Kd = 0.80 mM). PFT-μ reduces p53-mediated apoptosis induced by γ-radiation in mouse thymocytes in vitro and protects mice from doses of radiation that cause lethal hematopoietic syndrome. At 25 μM, PFT-μ reduces apoptosis triggered by nutlin-3, which inhibits MDM2/p53 binding and potentiates p53-mediated growth arrest and apoptosis. PFT-μ also interacts selectively with heat shock protein 70 (Hsp70), leading to disruption of the association between Hsp70 and many of its co-chaperones and substrate proteins.
Uses
Different sources of media describe the Uses of 64984-31-2 differently. You can refer to the following data:
1. A small molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation
2. Pifithrin-μ has been used:to treat microglial cell line to analyse its neuroprotective effect on M1-like and M2-like phenotypeas heat shock protein (HSP)-70 inhibitor, to treat transfected Marc-145 cellsto inhibit heat shock cognate 70 (Hsc70) to elucidate heat shock chaperones mouse embryonic stem cells
General Description
A cell-permeable sulfonamide that blocks p53 interaction with Bcl-xL and Bcl-2 proteins and selectively inhibits p53 translocation to mitochondria without affecting the transactivation function of p53. Effectively protects against γ radiation-induced cell death in vitro and animal lethality in vivo. Because Pifithrin-μ targets only the mitochondrial branch of the p53 pathway without affecting the important transcriptional functions of p53, it is superior to Pifithrin-α (Cat. No. 506132) in in vivo studies. Shown to selectively interact with inducible HSP70 and disrupt its functions.
Biological Activity
Inhibits p53 binding to mitochondria by reducing its affinity for antiapoptotic proteins Bcl-2 and Bcl-XL. Displays no effect on the transactivational or cell cycle checkpoint control function of p53. Potentially increases reprogramming efficiency of human somatic cells to induced pluripotent stem cells (iPSCs) by silencing p53. Reduces cell death induced by γ -radiation in vitro and protects mice from doses of radiation that cause lethal hematopoietic syndrome. Selectively inhibits heat shock protein 70 (HSP70) activity.
Biochem/physiol Actions
Pifithrin-μ is an inhibitor of p53 binding and anti-apoptotic, which directly inhibits p53 binding to mitochondria as well as to Bcl-xL and Bcl-2 proteins. PFTμ rescues cells from lethal γ-irradiation-induced cell death. Because pifithrin-μ shuts down only the p53-mitochondrial pathway without affecting the transcriptional functions of p53, it is superior to pifithrin-α.
Enzyme inhibitor
This cell-permeable sulfonamide-based inhibitor and anti-apoptotic factor (FW = 181.20 g/mol; CAS 64984-31-2; Solubility: >10 mg/mL DMSO, <2 mg/mL H2O; pKa = 8; Symbol = PFTμ and PAS), also known as 2- phenylethynesulfonamide, targets p53 and Heat Shock Protein-70, or HSP 70. Because it only targets the mitochondrial branch of the p53 pathway without affecting the important transcriptional functions of p53, Pifithrin-μ is recommended over Pifithrin-α for in vivo studies. PFTμ exhibits high specificity for p53 and does not protect cells from apoptosis induced by overexpression of the proapoptotic protein Bax or by treatment with dexamethasone. With B-chronic lymphocytic leukemia (CLL) cells, Pifithrin-μ (5–20 μM) initiated apoptosis within 24 hours, with maximal death at 48 hours, as assessed by cell morphology, cleavage of poly(ADPribose) polymerase (PARP), caspase-3 activation, and annexin V staining.
References
1) Leu et al. (2009), The therapeutic potential of p53 reactivation by nutlin-3a in ALK+ anaplastic large cell lymphoma with wild-type or mutated p53; Mol. Cell, 36 15
2) Strom et al. (2006), Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation.; Nat. Chem. Biol., 2 474
Check Digit Verification of cas no
The CAS Registry Mumber 64984-31-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,9,8 and 4 respectively; the second part has 2 digits, 3 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 64984-31:
(7*6)+(6*4)+(5*9)+(4*8)+(3*4)+(2*3)+(1*1)=162
162 % 10 = 2
So 64984-31-2 is a valid CAS Registry Number.
InChI:InChI=1/C8H7NO2S/c9-12(10,11)7-6-8-4-2-1-3-5-8/h1-5H,(H2,9,10,11)
64984-31-2Relevant articles and documents
Novel improved synthesis of hsp70 inhibitor, pifithrin-μ in vitro synergy quantification of pifithrin-μ combined with pt drugs in prostate and colorectal cancer cells
McKeon, Aoife M.,Egan, Alan,Chandanshive, Jay,McMahon, Helena,Griffith, Darren M.
, (2016)
We describe a novel improved approach to the synthesis of the important and well-known heat shock protein 70 inhibitor (HSP70), pifithrin-μ, with corresponding and previously unreported characterisation. The first example of a combination study comprising
HSP70 INHIBITORS AND METHODS OF USING SAME
-
Page/Page column 67; 73-74, (2021/10/11)
The disclosure provides compounds, and compositions comprising such compounds, that can be used to treat cancer, especially colorectal cancer (CRC). In certain embodiments, the compounds of the disclosure inhibit HSP70. In other embodiments, the compounds of the disclosure promote or increase immune cell recruitment to a cancer. In yet other embodiments, the compounds of the disclosure promote or increase immune cell infiltration in a cancer.
